Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM
Status: | Active, not recruiting |
---|---|
Conditions: | Infectious Disease, HIV / AIDS |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | July 2012 |
End Date: | November 2016 |
Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM
The study has the following primary aims: (1) to test whether participants assigned to CNU
(a 7-session, manualized intervention entitled "Connect 'n Unite") engage in lower HIV/STI
behavioral risk compared to participants assigned to WP (a wellness promotion attention
control condition); (2) to test whether participants assigned to CNU have lower cumulative
incidence of STIs—chlamydia and gonorrhea—confirmed via biological assay compared to
participants assigned to WP; and (3) to test whether participants assigned to CNU engage in
less drug use compared to participants assigned to WP.
(a 7-session, manualized intervention entitled "Connect 'n Unite") engage in lower HIV/STI
behavioral risk compared to participants assigned to WP (a wellness promotion attention
control condition); (2) to test whether participants assigned to CNU have lower cumulative
incidence of STIs—chlamydia and gonorrhea—confirmed via biological assay compared to
participants assigned to WP; and (3) to test whether participants assigned to CNU engage in
less drug use compared to participants assigned to WP.
This study addresses the overrepresentation of the African American/Black community among
those living with HIV/AIDS in the U.S. as well as men who have sex with men (MSM), the
transmission category that accounts for the majority of HIV infections. In the absence of a
vaccine or cure for HIV infection, behavioral risk reduction represents the best public
health tool for prevention of HIV transmission. The proposed randomized clinical trial will
rigorously test an innovative, couples-based intervention targeting the intersection of
stimulant use and sexual risk behavior among racial/ethnic and sexual minorities, with the
ultimate goal providing an evidence-based intervention that can be delivered in drug
treatment and other service settings to reduce the spread of HIV among stimulant-using,
African American/Black MSM.
those living with HIV/AIDS in the U.S. as well as men who have sex with men (MSM), the
transmission category that accounts for the majority of HIV infections. In the absence of a
vaccine or cure for HIV infection, behavioral risk reduction represents the best public
health tool for prevention of HIV transmission. The proposed randomized clinical trial will
rigorously test an innovative, couples-based intervention targeting the intersection of
stimulant use and sexual risk behavior among racial/ethnic and sexual minorities, with the
ultimate goal providing an evidence-based intervention that can be delivered in drug
treatment and other service settings to reduce the spread of HIV among stimulant-using,
African American/Black MSM.
Inclusion Criteria:
- Male
- At least 18 years old
- Report having a "primary/main male partner" operationalized as a male with whom he
has had an ongoing sexual relationship over the prior 6 months and has an emotional
bond with more than any person
- Self-identify as African American and/or Black, or identify having a main partner who
self-identifies in this manner
- Report using a illicit use of psychostimulant and/or psychoactive drugs in the past
90 days (or has a main male partner who meets this criterion)
- Report having unprotected anal sex with a man who is a non-main partner in the past
90 days (or has a main male partner who meets this criterion)
- Identify each other as their main partner
Exclusion Criteria:
- Either partner reports the occurrence of ≥1 incident of severe intimate partner
violence (IPV) within the relationship in the past year as assessed using the Revised
Conflict Tactics Scales
- Either partner has a language or cognitive impairment that prevents comprehension of
study procedures as assessed during informed consent
- Either partner reports being currently involved (i.e., has not completed the final
follow-up assessment) in an HIV prevention research study
We found this trial at
1
site
Click here to add this to my saved trials